undamentalytics Newsletter
Sign in

Connect Biopharma Holdings Ltd balance sheet

At the end of fiscal 2025, Connect Biopharma Holdings Ltd had total assets of $56.1m, total liabilities of $14.1m and shareholders' equity of $42.0m. It held $38.3m in cash against $0 of debt: net cash of $38.3m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents106783827
Receivables0103
Total current assets123975139
Total assets1271015643
Accounts payable2022
Deferred revenue (current)13000
Total current liabilities2581416
Total debt0000
Total liabilities2691417
Shareholders' equity101924227
Net debt (negative = net cash)−106−78−38−27
Shares outstanding55m55m56m63m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CNTB vs UPBCNTB vs XBIOCNTB vs VTGN

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Connect Biopharma Holdings Ltd's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Connect Biopharma Holdings Ltd.